TERT and central nervous system cancer: Radiomics performed on magnetic resonance imaging (MRI) were shown to predict molecular alterations such as IDH1/2 mutations [7,8], 1p19q co-deletion [9], ATRX status [10], MGMT promoter methylation [11] and also TERT promoter mutations [12] in gliomas with remarkable accuracy.